61 related articles for article (PubMed ID: 32243153)
1. AMPL: A Data-Driven Modeling Pipeline for Drug Discovery.
Minnich AJ; McLoughlin K; Tse M; Deng J; Weber A; Murad N; Madej BD; Ramsundar B; Rush T; Calad-Thomson S; Brase J; Allen JE
J Chem Inf Model; 2020 Apr; 60(4):1955-1968. PubMed ID: 32243153
[TBL] [Abstract][Full Text] [Related]
2. Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery.
Hinkson IV; Madej B; Stahlberg EA
Front Pharmacol; 2020; 11():770. PubMed ID: 32694991
[TBL] [Abstract][Full Text] [Related]
3. COMO: a pipeline for multi-omics data integration in metabolic modeling and drug discovery.
Bessell B; Loecker J; Zhao Z; Aghamiri SS; Mohanty S; Amin R; Helikar T; Puniya BL
Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37930022
[TBL] [Abstract][Full Text] [Related]
4. EasyAmplicon: An easy-to-use, open-source, reproducible, and community-based pipeline for amplicon data analysis in microbiome research.
Liu YX; Chen L; Ma T; Li X; Zheng M; Zhou X; Chen L; Qian X; Xi J; Lu H; Cao H; Ma X; Bian B; Zhang P; Wu J; Gan RY; Jia B; Sun L; Ju Z; Gao Y; Wen T; Chen T
Imeta; 2023 Feb; 2(1):e83. PubMed ID: 38868346
[TBL] [Abstract][Full Text] [Related]
5. Combining IC
Landrum GA; Riniker S
J Chem Inf Model; 2024 Mar; 64(5):1560-1567. PubMed ID: 38394344
[TBL] [Abstract][Full Text] [Related]
6. Exploring Chemical Reaction Space with Machine Learning Models: Representation and Feature Perspective.
Ding Y; Qiang B; Chen Q; Liu Y; Zhang L; Liu Z
J Chem Inf Model; 2024 Apr; 64(8):2955-2970. PubMed ID: 38489239
[TBL] [Abstract][Full Text] [Related]
7. QSARtuna: An Automated QSAR Modeling Platform for Molecular Property Prediction in Drug Design.
Mervin L; Voronov A; Kabeshov M; Engkvist O
J Chem Inf Model; 2024 Jul; ():. PubMed ID: 38950185
[TBL] [Abstract][Full Text] [Related]
8. Guiding discovery of protein sequence-structure-function modeling.
Hussain A; Brooks Iii CL
Bioinformatics; 2024 Jan; 40(1):. PubMed ID: 38195719
[TBL] [Abstract][Full Text] [Related]
9. Building A Novel AI-Driven Echocardiography Data Pipeline: Findings from a Large Learning Health System.
Bose B; Butt SA; Arshad HB; Nicolas CC; Gullapelli R; Nwana N; Javed Z; Shahid I; Pournazari P; Patel K; Chamsi Pasha MA; Little SH; Faza NS; Jones S; Cainzos MA; Al-Kindi S; Saad JM; Zoghbi W; Nagueh SF; Nasir K
J Am Soc Echocardiogr; 2024 Jun; ():. PubMed ID: 38830435
[No Abstract] [Full Text] [Related]
10. Discovery of Novel Aldose Reductase Inhibitors via the Integration of Ligand-Based and Structure-Based Virtual Screening with Experimental Validation.
Yasir M; Park J; Chun W
ACS Omega; 2024 May; 9(18):20338-20349. PubMed ID: 38737046
[TBL] [Abstract][Full Text] [Related]
11. Enhancing molecular design efficiency: Uniting language models and generative networks with genetic algorithms.
Bhowmik D; Zhang P; Fox Z; Irle S; Gounley J
Patterns (N Y); 2024 Apr; 5(4):100947. PubMed ID: 38645768
[TBL] [Abstract][Full Text] [Related]
12. Language models for the prediction of SARS-CoV-2 inhibitors.
Blanchard AE; Gounley J; Bhowmik D; Chandra Shekar M; Lyngaas I; Gao S; Yin J; Tsaris A; Wang F; Glaser J
Int J High Perform Comput Appl; 2022 Nov; 36(5-6):587-602. PubMed ID: 38603308
[TBL] [Abstract][Full Text] [Related]
13. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
14. A new workflow for the effective curation of membrane permeability data from open ADME information.
Esaki T; Yonezawa T; Ikeda K
J Cheminform; 2024 Mar; 16(1):30. PubMed ID: 38481269
[TBL] [Abstract][Full Text] [Related]
15. Vismodegib Identified as a Novel COX-2 Inhibitor via Deep-Learning-Based Drug Repositioning and Molecular Docking Analysis.
Yasir M; Park J; Han ET; Park WS; Han JH; Kwon YS; Lee HJ; Chun W
ACS Omega; 2023 Sep; 8(37):34160-34170. PubMed ID: 37744812
[TBL] [Abstract][Full Text] [Related]
16. Evaluating point-prediction uncertainties in neural networks for protein-ligand binding prediction.
Fan YJ; Allen JE; McLoughlin KS; Shi D; Bennion BJ; Zhang X; Lightstone FC
Artif Intell Chem; 2023 Jun; 1(1):. PubMed ID: 37583465
[TBL] [Abstract][Full Text] [Related]
17. Adaptive language model training for molecular design.
Blanchard AE; Bhowmik D; Fox Z; Gounley J; Glaser J; Akpa BS; Irle S
J Cheminform; 2023 Jun; 15(1):59. PubMed ID: 37291633
[TBL] [Abstract][Full Text] [Related]
18. Transporter proteins knowledge graph construction and its application in drug development.
Chen XH; Ruan Y; Liu YG; Duan XY; Jiang F; Tang H; Zhang HY; Zhang QY
Comput Struct Biotechnol J; 2023; 21():2973-2984. PubMed ID: 37235186
[TBL] [Abstract][Full Text] [Related]
19. Digital Research Environment(DRE)-enabled Artificial Intelligence (AI) to facilitate early stage drug development.
Barrett JS; Oskoui SE; Russell S; Borens A
Front Pharmacol; 2023; 14():1115356. PubMed ID: 37033647
[TBL] [Abstract][Full Text] [Related]
20. Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors.
Meqbil YJ; van Rijn RM
Pharmaceuticals (Basel); 2022 Jul; 15(7):. PubMed ID: 35890173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
